Nexome Capital Markets Receives BSE Trading Approval for Rights Issue Shares
Nexome Capital Markets Limited has received official trading approval from BSE for its 29,38,500 equity shares issued through rights basis at ₹75 per share. The trading approval, effective March 27, 2026, marks the successful completion of the company's ₹22,03,87,500 fundraising initiative which saw 100.79% oversubscription.

*this image is generated using AI for illustrative purposes only.
Nexome Capital Markets Limited (formerly SMIFS Capital Markets Limited) has received official trading approval from BSE Limited for its 29,38,500 equity shares issued on rights basis, marking the final milestone in its ₹22,03,87,500 fundraising initiative. The company confirmed receipt of BSE's trading approval letter dated March 25, 2026, with trading set to commence on March 27, 2026.
BSE Trading Approval Details
BSE Limited issued the trading approval through reference LOD/RIGHTS/SV/471/2025-2026 dated March 25, 2026, authorizing trading of equity shares bearing distinctive numbers 58,77,001 to 88,15,500. The approval covers shares issued at ₹75 per share (₹10 face value plus ₹65 premium) under the completed rights issue program.
| Trading Approval Specifications: | Details |
|---|---|
| Approved Shares: | 29,38,500 |
| Issue Price: | ₹75 per share |
| Face Value: | ₹10 per share |
| Premium: | ₹65 per share |
| Distinctive Numbers: | 58,77,001 to 88,15,500 |
| Trading Commencement: | March 27, 2026 |
Rights Issue Completion Timeline
The corporate action followed a structured timeline with all regulatory milestones achieved as per SEBI requirements. The Letter of Offer was dated February 24, 2026, with allotment completion on March 24, 2026, followed by share crediting and BSE communication on March 25, 2026.
| Timeline Details: | Date |
|---|---|
| Letter of Offer: | February 24, 2026 |
| Allotment Completion: | March 24, 2026 |
| Share Crediting: | March 25, 2026 |
| BSE Trading Approval: | March 25, 2026 |
| Trading Commencement: | March 27, 2026 |
Issue Performance and Capital Structure
The rights issue demonstrated strong investor response with oversubscription of 100.79% of the total issue size. Out of 143 total applications received, 87 valid applications resulted in the final allotment, successfully raising the targeted amount of ₹22,03,87,500.
| Post-Issue Capital Structure: | Details |
|---|---|
| Total Equity Shares: | 88,15,500 |
| Paid-up Capital: | ₹8,81,55,000 |
| Amount Raised: | ₹22,03,87,500 |
| Oversubscription: | 100.79% |
| Valid Applications: | 87 out of 143 |
Regulatory Compliance Confirmation
Company Secretary Sanjana Gupta confirmed completion of all regulatory formalities in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. BSE's Notice No. 20260325-51 dated March 25, 2026 was issued to Trading Members, officially notifying the listing and trading commencement of the new equity shares. The company has fulfilled all documentation requirements including newspaper advertisement publication and submission of required documents to the exchange.
Historical Stock Returns for Nexome Capital Markets
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.21% | +14.27% | +0.86% | +0.86% | +0.86% | +0.86% |
How will Nexome Capital Markets utilize the ₹22.04 crore raised funds for business expansion or strategic initiatives?
What impact might the 66% increase in share capital have on the company's earnings per share and dividend policy?
Will the successful oversubscription lead Nexome to consider additional fundraising rounds in the near future?


































